grant

Innovations and mechanisms in tumor subcellular metabolism

Organization STANFORD UNIVERSITYLocation STANFORD, UNITED STATESPosted 23 Sept 2021Deadline 31 Aug 2026
NIHUS FederalResearch GrantFY20244-O-beta-D-galactopyranosyl-D-glucoseAbnormal Assessment of MetabolismAutophagocytosisBiochemical ReactionBiologic ModelsBiological ModelsCancersCarbonCell BodyCell membraneCellsCytoplasmic MembraneD-GlucoseDextroseDiffusionEnvironmentEnzymatic ReactionEukaryotaEukaryoteEukaryotic CellEvolutionGene Action RegulationGene Expression RegulationGene RegulationGene Regulation ProcessGeneralized GrowthGeneticGlucoseGrowthHumanIntermediary MetabolismLac OperonLactoseLactose OperonLipidsLower OrganismLysosomesMalignant CellMalignant NeoplasmsMalignant Pancreatic NeoplasmMalignant TumorMalignant neoplasm of pancreasMediatingMetabolicMetabolic ProcessesMetabolic StudiesMetabolismMetabolism StudiesModel SystemModern ManMolecularNutrientNutrient availabilityO elementO2 elementOncogenesisOrganellesOxygenPancreas CancerPancreas Ductal AdenocarcinomaPancreatic CancerPancreatic Ductal AdenocarcinomaPathway interactionsPlasma MembraneProkaryotaeProkaryotic CellsProteinsRecyclingResolutionRoleSourceStromal CellsSystemTissue GrowthVascularizationWorkautophagybiological systemscancer cellcancer cell metabolismcancer metabolismcancer microenvironmentcell typedesigndesigningdiffuseddiffusesdiffusingdiffusionsextracellularflexibilityflexiblein vivoinnovateinnovationinnovativeinnovative technologiesmacromoleculemalignancymetabolic abnormality assessmentmouse modelmurine modelneoplasm/cancernew approachesnew drug targetnew druggable targetnew pharmacotherapy targetnew therapeutic targetnew therapy targetnovel approachesnovel drug targetnovel druggable targetnovel pharmacotherapy targetnovel strategiesnovel strategynovel therapeutic targetnovel therapy targetontogenypancreatic malignancypathwayplasmalemmaprokaryoteresolutionsresponsesocial rolestressortooltumortumor cell metabolismtumor metabolismtumor microenvironmenttumorigenesis
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project Summary/Abstract
Living cells require a constant supply of nutrients that provide energy and building blocks to support

their vital activities and growth. Fluctuations in nutrient availability are inevitable. Thus, to survive, cells need to

adapt to these changes by rewiring their metabolism. Studying this metabolic adaptation in lower organisms

has revolutionized our understanding of biological systems. For example, the discovery of how prokaryotes

respond to changes in the accessibility to lactose and glucose as a carbon source led to the concept of gene

regulation after the identification of the lac operon.

In eukaryotes the evolution of subcellular organelles provided an optimal environment for biochemical

reactions to proceed. Moreover, this system allowed the eukaryotic cell to evolve additional strategies to

acquire nutrients besides passive diffusion or transport across the cell membrane. Through the endo-

lysosomal compartment, cells can scavenge nutrients from extracellular macromolecules, which provides them

with metabolic flexibility to survive various states of nutrient availability by balancing the composition of their

microenvironment with their nutrient demands.

Nutrient acquisition strategies are fully exploited by malignant cells to survive the harsh tumor

microenvironment. Pancreatic cancer, a lethal malignancy, is a paradigm of metabolic adaptation. Hypo-

vascularization of pancreatic ductal adenocarcinoma (PDAC) limits the delivery of free nutrients and oxygen to

cancer cells. To overcome nutrient scarcity, cancer and stromal cells rely on scavenging nutrients from intra-

and extracellular macromolecules via autophagy and macropinocytosis, respectively. Both pathways converge

on the lysosome, a cellular organelle that degrades macromolecules to recycle their nutrient content.

Despite their essential role in cancer, studying lysosomes in highly heterogenous tumors in vivo is

challenging because of the lack of tools that allow the functional profiling of lysosomal content during

tumorigenesis at a cell-type-specific resolution. In this proposal, I will describe our novel approach to develop

an innovative technology that allows the rapid capturing of lysosomes from specific cell types in the tumor to

profile their metabolite, lipid and protein contents to understand how lysosomes in malignant and stromal cells

mediate metabolic adaptation. We will also design a modular mouse model system that will allow the selective

interrogation of the lysosomal response to major metabolic stressors that exist in the tumor microenvironment.

Our innovative approaches combined with functional characterization of the lysosomal components

using genetic tools will result in an unprecedent subcellular and cell-type-specific understanding of tumor

metabolism. We believe that our work has the potential to revolutionize our understanding of metabolic

adaptation in mammalian systems, and to identify vulnerabilities that can be exploited as novel therapeutic

targets in pancreatic cancer.

Grant Number: 4DP2CA271386-02
NIH Institute/Center: NIH

Principal Investigator: Monther Abu-Remaileh

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →